Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting

INTRODUCTION: Randomized trials indicate that adjuvant radiotherapy plus tamoxifen decrease the five-year risk of recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery from about 20% to 8%. The aims of this study were to examine the use and impact of these therapi...

Descripción completa

Detalles Bibliográficos
Autores principales: Habel, Laurel A, Achacoso, Ninah S, Haque, Reina, Nekhlyudov, Larissa, Fletcher, Suzanne W, Schnitt, Stuart J, Collins, Laura C, Geiger, Ann M, Puligandla, Balaram, Acton, Luana, Quesenberry, Charles P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815548/
https://www.ncbi.nlm.nih.gov/pubmed/19922614
http://dx.doi.org/10.1186/bcr2453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815548/
https://www.ncbi.nlm.nih.gov/pubmed/19922614
http://dx.doi.org/10.1186/bcr2453

Ejemplares similares